Toshiaki Onitsuka Selected Research

Toshiaki Onitsuka Research Topics

23	Schizophrenia (Dementia Praecox) 07/2023 - 08/2003
5	Major Depressive Disorder (Major Depressive Disorders) 01/2023 - 10/2019
3	Mental Disorders (Mental Disorder) 01/2022 - 01/2016
2	Autistic Disorder (Autism) 03/2024 - 01/2022
2	Autism Spectrum Disorder 03/2024 - 01/2022
2	Mood Disorders (Mood Disorder) 01/2023 - 10/2019
2	Treatment-Resistant Schizophrenia 10/2022 - 01/2022
2	Bipolar Disorder (Manic Depressive Psychosis) 01/2022 - 02/2021
1	Neuroinflammatory Diseases 03/2024
1	Catatonia 08/2013
1	Psychotic Disorders (Schizoaffective Disorder) 08/2003

9	Antipsychotic Agents (Antipsychotics)IBA 07/2023 - 01/2018
7	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2016
3	Hypnotics and Sedatives (Sedatives)IBA 07/2023 - 01/2022
3	Clozapine (Clozaril)FDA LinkGeneric 01/2023 - 01/2022
3	Antidepressive Agents (Antidepressants)IBA 01/2023 - 01/2022
3	Cholinergic Antagonists (Anticholinergics)IBA 11/2022 - 01/2022
2	Oxytocin (Pitocin)FDA LinkGeneric 03/2024 - 01/2022
2	Indicators and Reagents (Reagents)IBA 01/2023 - 01/2020
2	Anti-Anxiety Agents (Anxiolytics)IBA 12/2022 - 01/2022
1	CytokinesIBA 03/2024
1	N-acetyltryptophanamide (NATA)IBA 12/2022
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2022
1	Glutamic Acid (Glutamate)FDA Link 10/2016
1	Neurotransmitter Agents (Neurotransmitter)IBA 11/2013
1	Zolpidem (Ambien)FDA LinkGeneric 08/2013
1	Temazepam (Nocturne)FDA LinkGeneric 08/2003